Influenza Vaccine
Protein Sciences licenses FluBlOk to UMN Pharma for Japan market
Published in Medical Letter on the CDC and FDA, October 1st, 2006
PSC will transfer technology to UMN, which will be responsible for the registration, manufacture, marketing and sale of FluBlOk in Japan. Applications include annual and pandemic use of FluBlOk.
After registration is achieved, UMN will buy commercial quantities of FluBlOk from PSC until a commercial manufacturing facility is available in Japan. The license terms include a multimillion dollar up front payment and double digit royalties.
FluBlOk has received "accelerated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Antimicrobial Resistance
Carbapenem resistance in Klebsiella is not detected by susceptibility testing - Food Safety
Infections associated with cantaloupe are growing public health concern - Meningitis Risk Factors
Invasive Enterobacter sakazakii disease in infants was examined - Meningitis Vaccine
Hib conjugate vaccine was effective in children in Kenya - Occupational Exposure
Workplace conditions frequently exacerbate asthma - Addiction Medicine
Drug treatment programs reduce criminal behavior - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
